secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2026-07-22T21:26:11+00:00
Accession:  0001213900-26-080475
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma prices $5M registered direct offering of 2.5M shares at $2/share
-----------------------------------------------------------------------------

- Gross proceeds of $5M from sale of 2.5M shares at $2.00 per share.
- FT Global Capital acting as exclusive placement agent; 7% cash fee.
- Net proceeds to be used for working capital and general corporate purposes.
- Investor gets 40% participation right in subsequent financings for 3 months; 91-day lock-up on variable rate transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390026080475/0001213900-26-080475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390026080475/ea0298921-8k_china.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-080475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer